Product Code: GVR-4-68039-052-8
D-dimer Testing Market Growth & Trends:
The global D-dimer testing market size is expected to reach USD 2.46 billion in 2030 and is projected to grow at a CAGR of 4.5% from 2025 to 2030. Technological advancements in D-dimer testing have resulted in the development of a wide range of products that have allowed healthcare professionals to offer suitable emergency assistance to patients. The concept of automation in D-dimer testing has provided rapid, less labor-intensive, and user-friendly diagnostic strategies, which is expected to drive the market in the near future.
The commercially available assays often have differences in their antibody specificity as D-dimer antibodies also detect Fibrin Degradation Products (FDPs), leading to incorrect results. To address this issue, Advanced ImmunoChemical, Inc. has developed two monoclonal antibodies, which are used to design one-step immunoassay specific for both FDP and D-dimer. Thus, the development of improved immunoassays that equally detect all FDPs is expected to boost the market growth.
Extensive research for the determination of new D-dimer threshold values for a specific population set prevents the usage of Computed Tomography Pulmonary Angiography (CTPA). This is beneficial as the elimination of CTPA leads to low radiation exposure, which, in turn, increases the demand for the test. To demonstrate this, a group of researchers from Japan determined new elevated D-dimer threshold values for the diagnosis of pulmonary embolism in the Japanese population. Such studies are expected to favor market growth.
D-dimer Testing Market Report Highlights:
- Reagents and consumables accounted for the largest revenue share in 2024 owing to the wide availability and frequent usage of reagents in the market space
- Presence of blocking agents that reduce the interferences from heterophilic antibodies to increase the efficiency of immunoassays boost the reagents and consumables segment
- Shorter turnaround times, ease of use, and generation of gold-standard quality results are among the few factors that lead to a lucrative growth of point-of-care testing
- Enzyme-linked Immunosorbent Assays (ELISA) held the largest revenue share because microplate ELISA is considered as a reference method due to its high sensitivity for coagulation markers
- Deep Vein Thrombosis (DVT) dominated the revenue share in 2024 as this test is a reliable method and is used as a routine screening test for DVT
- The hospitals' segment accounted for the maximum revenue share in 2024
- This is attributive to a rise in the rate of pulmonary embolism cases in hospitalized patients, which results in high adoption of the test in hospitals
- Asia Pacific is expected to witness a lucrative CAGR due to a rise in the funding initiatives that support research studies related to the usage of these assays in various diseases
- The National Natural Science Foundation of China and the Fundamental Research Funds for the Central Universities are among the few agencies involved in funding research studies in China
- Key companies operating in the market have undertaken several growth initiatives to expand their product portfolio
- For instance, in February 2019, HORIBA introduced the Yumizen D-Dimer reagent kit for measurement and reference exclusion testing for DVT and pulmonary embolism.
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.2. Segment Definitions
- 1.2.1. Product
- 1.2.2. Test Type
- 1.2.3. Method
- 1.2.4. Application
- 1.2.5. End Use
- 1.3. Estimates and Forecast Timeline
- 1.4. Research Methodology
- 1.5. Information Procurement
- 1.5.1. Purchased Database
- 1.5.2. GVR's Internal Database
- 1.5.3. Secondary Sources
- 1.5.4. Primary Research
- 1.6. Information Analysis
- 1.6.1. Data Analysis Models
- 1.7. Market Formulation & Data Visualization
- 1.8. Model Details
- 1.8.1. Commodity Flow Analysis
- 1.9. List of Secondary Sources
- 1.10. Objectives
Chapter 2. Executive Summary
- 2.1. Market Snapshot
- 2.2. Segment Snapshot
- 2.3. Competitive Landscape Snapshot
Chapter 3. D-dimer Testing Market Variables, Trends, & Scope
- 3.1. Market Lineage Outlook
- 3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
- 3.2.2. Market Restraint Analysis
- 3.3. Business Environment Analysis
- 3.3.1. Industry Analysis - Porter's Five Forces Analysis
- 3.3.1.1. Supplier Power
- 3.3.1.2. Buyer Power
- 3.3.1.3. Substitution Threat
- 3.3.1.4. Threat of New Entrants
- 3.3.1.5. Competitive Rivalry
- 3.3.2. PESTLE Analysis
Chapter 4. D-dimer Testing Market: Product Business Analysis
- 4.1. Product Market Share, 2024 & 2030
- 4.2. Product Segment Dashboard
- 4.3. Market Size & Forecasts and Trend Analysis, by Product, 2018 to 2030 (USD Million)
- 4.4. Analyzers
- 4.4.1. Analyzers Market, 2018 - 2030 (USD Million)
- 4.5. Reagents & Consumables
- 4.5.1. Reagents & Consumables Market, 2018 - 2030 (USD Million)
Chapter 5. D-dimer Testing Market: Test Type Business Analysis
- 5.1. Test Type Market Share, 2024 & 2030
- 5.2. Test Type Segment Dashboard
- 5.3. Market Size & Forecasts and Trend Analysis, by Test Type, 2018 to 2030 (USD Million)
- 5.4. Clinical Laboratory Tests
- 5.4.1. Clinical Laboratory Tests Market, 2018 - 2030 (USD Million)
- 5.5. Point-of-Care Tests
- 5.5.1. Point-of-Care Tests Market, 2018 - 2030 (USD Million)
Chapter 6. D-dimer Testing Market: Method Business Analysis
- 6.1. Method Market Share, 2024 & 2030
- 6.2. Method Segment Dashboard
- 6.3. Market Size & Forecasts and Trend Analysis, by Method, 2018 to 2030 (USD Million)
- 6.4. Enzyme-linked Immunosorbent Assay (ELISA)
- 6.4.1. Enzyme-linked Immunosorbent Assay (ELISA) Market, 2018 - 2030 (USD Million)
- 6.5. Latex-enhanced Immunoturbidimetric Assays
- 6.5.1. Latex-enhanced Immunoturbidimetric Assays Market, 2018 - 2030 (USD Million)
- 6.6. Fluorescence Immunoassays
- 6.6.1. Fluorescence Immunoassays Market, 2018 - 2030 (USD Million)
- 6.7. Others
- 6.7.1. Others Market, 2018 - 2030 (USD Million)
Chapter 7. D-dimer Testing Market: Application Business Analysis
- 7.1. Application Market Share, 2024 & 2030
- 7.2. Application Segment Dashboard
- 7.3. Market Size & Forecasts and Trend Analysis, by Application, 2018 to 2030 (USD Million)
- 7.4. Deep Vein Thrombosis (DVT)
- 7.4.1. Deep Vein Thrombosis (DVT) Market, 2018 - 2030 (USD Million)
- 7.5. Pulmonary Embolism (PE)
- 7.5.1. Pulmonary Embolism (PE) Market, 2018 - 2030 (USD Million)
- 7.6. Disseminated Intravascular Coagulation (DIC)
- 7.6.1. Disseminated Intravascular Coagulation (DIC) Market, 2018 - 2030 (USD Million)
- 7.7. Others
- 7.7.1. Others Market, 2018 - 2030 (USD Million)
Chapter 8. D-dimer Testing Market: End Use Business Analysis
- 8.1. End Use Market Share, 2024 & 2030
- 8.2. End Use Segment Dashboard
- 8.3. Market Size & Forecasts and Trend Analysis, by End Use, 2018 to 2030 (USD Million)
- 8.4. Hospitals
- 8.4.1. Hospitals Market, 2018 - 2030 (USD Million)
- 8.5. Academic & Research Institutes
- 8.5.1. Academic & Research Institutes Market, 2018 - 2030 (USD Million)
- 8.6. Diagnostic Centers
- 8.6.1. Diagnostic Centers Market, 2018 - 2030 (USD Million)
- 8.7. Others
- 8.7.1. Others Market, 2018 - 2030 (USD Million)
Chapter 9. D-dimer Testing Market: Regional Estimates & Trend Analysis by Product, Test Type, Method, Application, and End Use
- 9.1. Regional Market Share Analysis, 2024 & 2030
- 9.2. Regional Market Dashboard
- 9.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
- 9.4. North America
- 9.4.1. North America D-dimer Testing Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
- 9.4.2. U.S.
- 9.4.2.1. Key Country Dynamics
- 9.4.2.2. Regulatory Framework
- 9.4.2.3. Competitive Insights
- 9.4.2.4. U.S. D-dimer Testing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.4.3. Canada
- 9.4.3.1. Key Country Dynamics
- 9.4.3.2. Regulatory Framework
- 9.4.3.3. Competitive Insights
- 9.4.3.4. Canada D-dimer Testing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.4.4. Mexico
- 9.4.4.1. Key Country Dynamics
- 9.4.4.2. Regulatory Framework
- 9.4.4.3. Competitive Insights
- 9.4.4.4. Mexico D-dimer Testing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.5. Europe
- 9.5.1. Europe D-dimer Testing Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
- 9.5.2. UK
- 9.5.2.1. Key Country Dynamics
- 9.5.2.2. Regulatory Framework
- 9.5.2.3. Competitive Insights
- 9.5.2.4. UK D-dimer Testing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.5.3. Germany
- 9.5.3.1. Key Country Dynamics
- 9.5.3.2. Regulatory Framework
- 9.5.3.3. Competitive Insights
- 9.5.3.4. Germany D-dimer Testing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.5.4. France
- 9.5.4.1. Key Country Dynamics
- 9.5.4.2. Regulatory Framework
- 9.5.4.3. Competitive Insights
- 9.5.4.4. France D-dimer Testing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.5.5. Italy
- 9.5.5.1. Key Country Dynamics
- 9.5.5.2. Regulatory Framework
- 9.5.5.3. Competitive Insights
- 9.5.5.4. Italy D-dimer Testing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.5.6. Spain
- 9.5.6.1. Key Country Dynamics
- 9.5.6.2. Regulatory Framework
- 9.5.6.3. Competitive Insights
- 9.5.6.4. Spain D-dimer Testing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.5.7. Norway
- 9.5.7.1. Key Country Dynamics
- 9.5.7.2. Regulatory Framework
- 9.5.7.3. Competitive Insights
- 9.5.7.4. Norway D-dimer Testing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.5.8. Denmark
- 9.5.8.1. Key Country Dynamics
- 9.5.8.2. Regulatory Framework
- 9.5.8.3. Competitive Insights
- 9.5.8.4. Denmark D-dimer Testing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.5.9. Sweden
- 9.5.9.1. Key Country Dynamics
- 9.5.9.2. Regulatory Framework
- 9.5.9.3. Competitive Insights
- 9.5.9.4. Sweden D-dimer Testing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.6. Asia Pacific
- 9.6.1. Asia Pacific D-dimer Testing Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
- 9.6.2. Japan
- 9.6.2.1. Key Country Dynamics
- 9.6.2.2. Regulatory Framework
- 9.6.2.3. Competitive Insights
- 9.6.2.4. Japan D-dimer Testing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.6.3. China
- 9.6.3.1. Key Country Dynamics
- 9.6.3.2. Regulatory Framework
- 9.6.3.3. Competitive Insights
- 9.6.3.4. China D-dimer Testing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.6.4. India
- 9.6.4.1. Key Country Dynamics
- 9.6.4.2. Regulatory Framework
- 9.6.4.3. Competitive Insights
- 9.6.4.4. India D-dimer Testing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.6.5. South Korea
- 9.6.5.1. Key Country Dynamics
- 9.6.5.2. Regulatory Framework
- 9.6.5.3. Competitive Insights
- 9.6.5.4. South Korea D-dimer Testing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.6.6. Australia
- 9.6.6.1. Key Country Dynamics
- 9.6.6.2. Regulatory Framework
- 9.6.6.3. Competitive Insights
- 9.6.6.4. Australia D-dimer Testing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.6.7. Thailand
- 9.6.7.1. Key Country Dynamics
- 9.6.7.2. Regulatory Framework
- 9.6.7.3. Competitive Insights
- 9.6.7.4. Thailand D-dimer Testing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.7. Latin America
- 9.7.1. Latin America D-dimer Testing Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
- 9.7.2. Brazil
- 9.7.2.1. Key Country Dynamics
- 9.7.2.2. Regulatory Framework
- 9.7.2.3. Competitive Insights
- 9.7.2.4. Brazil D-dimer Testing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.7.3. Argentina
- 9.7.3.1. Key Country Dynamics
- 9.7.3.2. Regulatory Framework
- 9.7.3.3. Competitive Insights
- 9.7.3.4. Argentina D-dimer Testing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.8. MEA
- 9.8.1. MEA D-dimer Testing Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
- 9.8.2. South Africa
- 9.8.2.1. Key Country Dynamics
- 9.8.2.2. Regulatory Framework
- 9.8.2.3. Competitive Insights
- 9.8.2.4. South Africa D-dimer Testing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.8.3. Saudi Arabia
- 9.8.3.1. Key Country Dynamics
- 9.8.3.2. Regulatory Framework
- 9.8.3.3. Competitive Insights
- 9.8.3.4. Saudi Arabia D-dimer Testing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.8.4. UAE
- 9.8.4.1. Key Country Dynamics
- 9.8.4.2. Regulatory Framework
- 9.8.4.3. Competitive Insights
- 9.8.4.4. UAE D-dimer Testing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.8.5. Kuwait
- 9.8.5.1. Key Country Dynamics
- 9.8.5.2. Regulatory Framework
- 9.8.5.3. Competitive Insights
- 9.8.5.4. Kuwait D-dimer Testing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
Chapter 10. Competitive Landscape
- 10.1. Participant Overview
- 10.2. Company Market Position Analysis
- 10.3. Company Categorization
- 10.4. Strategy Mapping
- 10.5. Company Profiles/Listing
- 10.5.1. Thermo Fisher Scientific Inc.
- 10.5.1.1. Overview
- 10.5.1.2. Financial Performance
- 10.5.1.3. Product Benchmarking
- 10.5.1.4. Strategic Initiatives
- 10.5.2. F. Hoffmann-La Roche Ltd
- 10.5.2.1. Overview
- 10.5.2.2. Financial Performance
- 10.5.2.3. Product Benchmarking
- 10.5.2.4. Strategic Initiatives
- 10.5.3. Siemens Healthcare
- 10.5.3.1. Overview
- 10.5.3.2. Financial Performance
- 10.5.3.3. Product Benchmarking
- 10.5.3.4. Strategic Initiatives
- 10.5.4. Abbott
- 10.5.4.1. Overview
- 10.5.4.2. Financial Performance
- 10.5.4.3. Product Benchmarking
- 10.5.4.4. Strategic Initiatives
- 10.5.5. BIOMERIEUX
- 10.5.5.1. Overview
- 10.5.5.2. Financial Performance
- 10.5.5.3. Product Benchmarking
- 10.5.5.4. Strategic Initiatives
- 10.5.6. WERFEN
- 10.5.6.1. Overview
- 10.5.6.2. Financial Performance
- 10.5.6.3. Product Benchmarking
- 10.5.6.4. Strategic Initiatives
- 10.5.7. HORIBA, Ltd.
- 10.5.7.1. Overview
- 10.5.7.2. Financial Performance
- 10.5.7.3. Product Benchmarking
- 10.5.7.4. Strategic Initiatives
- 10.5.8. QuidelOrtho Corporation
- 10.5.8.1. Overview
- 10.5.8.2. Financial Performance
- 10.5.8.3. Product Benchmarking
- 10.5.8.4. Strategic Initiatives
- 10.5.9. Diazyme Laboratories
- 10.5.9.1. Overview
- 10.5.9.2. Financial Performance
- 10.5.9.3. Product Benchmarking
- 10.5.9.4. Strategic Initiatives
- 10.5.10. Biomedica Diagnostics
- 10.5.10.1. Overview
- 10.5.10.2. Financial Performance
- 10.5.10.3. Product Benchmarking
- 10.5.10.4. Strategic Initiatives
- 10.5.11. SEKISUI Diagnostics
- 10.5.11.1. Overview
- 10.5.11.2. Financial Performance
- 10.5.11.3. Product Benchmarking
- 10.5.11.4. Strategic Initiatives